• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GMBH ARCHITECT INSULIN REAGENT KIT; RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GMBH ARCHITECT INSULIN REAGENT KIT; RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN Back to Search Results
Catalog Number 08K41-28
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/10/2023
Event Type  malfunction  
Event Description
The customer reported falsely elevated architect insulin, which was not consistent with patient's clinical presentation and/or history and provided the following data for 1 patient: insulin laboratory results: (unit of measure is uu/ml) (b)(6) 2023 result was 144.5, 12 oct 2023 result was 130.6, 23 oct 2023 result was 123.2, roche result was 22.91 (date unknown).Other laboratory results: a1c = 6.8%, fasting glucose = 154.71, insulin resistance = 8.8.There was no reported impact to patient management.
 
Manufacturer Narrative
All available patient information was included.Additional patient details are not available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event Description
The customer reported falsely elevated architect insulin, which was not consistent with patient's clinical presentation and/or history and provided the following data for 1 patient: insulin laboratory results: (unit of measure is uu/ml).(b)(6) 2023 result was 144.5.(b)(6) 2023 result was 130.6.(b)(6) 2023 result was 123.2.Roche result was 22.91 (date unknown).Other laboratory results: a1c = 6.8%.Fasting glucose = 154.71.Insulin resistance = 8.8.There was no reported impact to patient management.
 
Manufacturer Narrative
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and field data review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.The ticket search by lot did not identify an increase in complaint activity.Ticket and trending review did not identify any trends related to customer reported event.Device history review did not identify any non-conformances, potential non-conformances or deviations with the complaint lot and customer reported event.The overall performance of the architect insulin reagent in the field was reviewed using data gathered from customers worldwide.The review of field data indicated that the patient median result for lot 54221lp21 is within the established control limits.Therefore, no unusual reagent lot performance was identified.Labeling was reviewed and sufficiently addresses the customer¿s reported issue.Based on the investigation, no systemic issue or deficiency was identified for the architect insulin reagent lot 54221lp21.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT INSULIN REAGENT KIT
Type of Device
RADIOIMMUNOASSAY, IMMUNOREACTIVE INSULIN
Manufacturer (Section D)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GMBH
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key18058912
MDR Text Key327207581
Report Number3002809144-2023-00455
Device Sequence Number1
Product Code CFP
UDI-Device Identifier00380740169824
UDI-Public00380740169824
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/02/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number08K41-28
Device Lot Number54221LP21
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/16/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/05/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2K PROC MOD, 03M74-01, (B)(6) ; ARC I2K PROC MOD, 03M74-01, (B)(6)
-
-